Intellia 治療公司
DE ˙ DB ˙ US45826J1051
€13.00 ↑1.80 (16.07%)
2026-06-04
分享價格
SecurityDE:38I / Intellia Therapeutics, Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership0 shares
Ownership 0.00%
Vanguard Group Inc ownership in 38I / Intellia Therapeutics, Inc.

2026-03-27 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Intellia Therapeutics, Inc. (DE:38I). This represents 0.0 percent ownership of the company. In their previous filing dated 2026-01-30 , Vanguard Group Inc had reported owning 13,010,001 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-03-27 2026-03-27 13G/A 13,010,001 0 -100.00 0.00 -100.00
2026-01-30 2026-01-30 13G/A 10,189,953 13,010,001 27.67 11.23 12.30
2025-01-08 2025-01-08 13G/A 8,347,449 10,189,953 22.07 10.00 7.30
2024-02-13 2024-02-13 13G/A 7,810,226 8,347,449 6.88 9.32 0.43
2023-02-09 2023-02-09 13G/A 6,442,355 7,810,226 21.23 9.28 7.16
2022-02-10 2022-02-10 13G/A 5,131,197 6,442,355 25.55 8.66 8.52
2021-02-10 2021-02-10 13G/A 3,524,199 5,131,197 45.60 7.98 10.83
2020-02-12 2020-02-12 13G/A 2,746,126 3,524,199 28.33 7.20 13.92
2019-02-11 2019-02-11 13G 2,746,126 6.32

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 13,010,001 1,965,181 17.79 116,960 -38.68 0.0017
2025-11-07 2025-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 11,044,820 192,651 1.78 190,744 87.38 0.0029
2025-08-11 2025-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 10,852,169 100,138 0.93 101,793 33.16 0.0016
2025-05-09 2025-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 10,752,031 561,978 5.51 76,447 -35.66 0.0014
2025-02-11 2024-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 10,190,053 562,249 5.84 118,816 -39.95 0.0021
2024-11-13 2024-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 9,627,804 527,736 5.80 197,851 -2.85 0.0035
2024-08-13 2024-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 9,100,068 6,356 0.07 203,660 -18.59 0.0039
2024-05-10 2024-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 9,093,712 746,263 8.94 250,168 -1.71 0.0050
2024-03-11 2023-12-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 8,347,449 155,579 1.90 254,514 -1.74 0.0056
2024-02-14 2023-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 8,347,449 155,579 254,514 0.0048
2023-12-18 2023-09-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 8,191,870 6,719 0.08 259,027 -22.40 0.0064
2023-11-14 2023-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 8,191,870 6,719 259,027 0.0011
2023-08-14 2023-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 8,185,151 52,373 0.64 333,790 10.12 0.0079
2023-07-14 2023-03-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 8,132,778 322,552 4.13 303,109 11.23 0.0077
2023-05-15 2023-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 8,132,778 322,552 303,109 0.0077
2023-02-10 2022-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 7,810,226 1,192,903 18.03 272,499 -26.41 0.0074
2022-11-14 2022-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 6,617,323 108,041 1.66 370,305 9.91 0.0109
2022-08-12 2022-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 6,509,282 117,342 1.84 336,920 -27.47 0.0095
2022-05-13 2022-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 6,391,940 -50,415 -0.78 464,502 -39.02 0.0110
2022-02-14 2021-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 6,442,355 89,021 1.40 761,744 -10.62 0.0173
2021-11-12 2021-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 6,353,334 327,157 5.43 852,299 -12.65 0.0212
2021-08-13 2021-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 6,026,177 447,433 8.02 975,698 117.92 0.0243
2021-05-14 2021-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 5,578,744 447,547 8.72 447,722 60.40 0.0121
2021-02-12 2020-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 5,131,197 754,398 17.24 279,137 220.81 0.0081
2020-11-16 2020-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 4,376,799 119,603 2.81 87,010 -2.77 0.0029
2020-08-14 2020-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 4,257,196 768,947 22.04 89,486 109.76 0.0032
2020-05-15 2020-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 3,488,249 -35,950 -1.02 42,661 -17.49 0.0018
2020-02-14 2019-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 3,524,199 71,738 2.08 51,701 12.17 0.0018
2019-11-14 2019-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 3,452,461 268,345 8.43 46,092 -11.57 0.0017
2019-08-14 2019-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 3,184,116 371,724 13.22 52,124 8.51 0.0020
2019-05-15 2019-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 2,812,392 66,266 2.41 48,035 28.14 0.0019
2019-02-14 2018-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 2,746,126 92,961 3.50 37,485 -50.63 0.0017
2018-12-13 2018-09-30 13F/A-2 INTELLIA THERAPEUTICS COM 45826J105 2,653,165 287,682 12.16 75,934 17.33 0.0030
2018-11-23 2018-09-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 2,653,165 0 75,934 0.0030
2018-11-14 2018-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 2,653,165 287,682 75,934
2018-08-14 2018-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 2,365,483 355,970 17.71 64,720 52.71 0.0027
2018-05-15 2018-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 2,009,513 173,032 9.42 42,381 20.07 0.0019
2018-02-14 2017-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,836,481 791,188 75.69 35,297 35.88 0.0015
2017-11-14 2017-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,045,293 48,005 4.81 25,976 62.79 0.0012
2017-08-24 2017-06-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 997,288 92,580 10.23 15,957 25.18 0.0008
2017-08-11 2017-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 997,288 92,580 15,957
2017-05-12 2017-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 904,708 33,925 3.90 12,747 11.66 0.0007
2017-02-14 2016-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 870,783 431,153 98.07 11,416 52.56 0.0006
2016-11-14 2016-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 439,630 23,066 5.54 7,483 -15.86 0.0004
2016-08-10 2016-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 416,564 416,564 8,894 0.0006
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.